Healthy Clinical Trial
Official title:
Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans
The aim of this study is to characterize the role of central norepinephrine and acetylcholine on reward and emotion related information processing in healthy volunteers using behavioural tasks and pupillometry (with eye tracking equipment). The pharmacological compounds used in the study (reboxetine and rivastigmine) are used as tools to manipulate these systems rather than to treat patients. The aim of the study is not to study the clinical effects, pharmacodynamics, adverse reactions, absorption, distribution, metabolism or excretion of the drugs. Further, the population studied is non-clinical, the drugs are not administered in a therapeutic dosing regimen (only a single dose of study drug will be administered) and the investigators do not measure clinically significant outcomes.
Background: Previous research has shown that human learners are able to encode the
probabilities of positive and negative outcomes in parallel, and adjust their learning
behaviour to the information content of positive and negative outcomes (Pulcu and Browning
2017). In reinforcement learning tasks, the volatility (also known as unexpected uncertainty
arising when the environment changes suddenly) of outcomes directly influences how
informative the outcomes are perceived to be (Behrens, Woolrich et al. 2007). Previous
studies consistently shown that human participants use a higher learning rate while learning
from outcomes with high volatility (Behrens, Woolrich et al. 2007, Browning, Behrens et al.
2015, Pulcu and Browning 2017). Another source of uncertainty is expected uncertainty, which
arises from naturally varying outcomes (e.g. day to day changes in temperature). Different
sources of uncertainty in the environment are argued to be associated with the activity of
different neurotransmitter systems in the human brain (Yu and Dayan, 2005)(Angela and Dayan
2005). For example, outcome volatility (unexpected uncertainty) is thought to be associated
with the activity of the central norepinephrine (NE) system, whereas outcome variation
(expected uncertainty) has been linked to the cholinergic (ACY) system.
Studies using pupillometry (a non-invasive way of inferring central norepinephrine activity
in the human brain) showed that pupil size is associated with the volatility of outcomes
during reinforcement learning tasks (Browning, Behrens et al. 2015, Pulcu and Browning 2017).
However, pupil size can also be influenced by the activity of other neurotransmitters
including acetylcholine limiting the degree to which these results can be attributed to the
NE system. Further, previous human studies have been associational in nature and thus the
causal role of the NE and ACY systems in human learning under uncertainty have yet to be
tested. The current study will address this knowledge gap by investigating how administering
a single dose of the norepinephrine reuptake inhibitor reboxetine or cholinesterase inhibitor
rivastigmine influence choice behaviour and pupillary correlates of human reinforcement
learning.
Study Structure: All participants will be recruited via the recruitment pipeline described
below. The randomisation procedure used will treat participants as if 2 parallel studies were
running: a reboxetine vs. placebo and a rivastigmine vs. placebo study. Researchers will
assign participants to either the reboxetine or rivastigmine arm (NB researchers will not be
blind to this allocation although participants will be). Both studies will randomise
participants in a 1:1 ratio, stratified by gender, to either the active drug or placebo (NB
both researchers and participants will remain blind to this allocation). This will result in
an overall group size for the reboxetine:rivastigmine:placebo groups of 30:30:60 (with
participants randomised to placebo being specifically associated with the reboxetine or
rivastigmine group). The rationale for this approach is that, while study procedures are
identical for all participants, the investigators are addressing 2 separate questions in this
study (the effect of NE manipulation and the effect of ACY manipulation on learning) which
are more straightforwardly assessed using two, separate, placebo controlled comparisons
rather than a larger three group study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |